Doc2u

Toulouse, France Founded: 2019 • Age: 7 yrs Acquired By Biosynex
Digital remote health monitoring devices are provided to healthcare providers.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 11 Brand Intelligence

About Doc2u

Doc2u is a company based in Toulouse (France) founded in 2019 was acquired by Biosynex in October 2022. Doc2u offers products and services including Telemedicine Platform and Tensioflash. Doc2u operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, Athelas and BioIntelliSense, among others.

  • Headquarter Toulouse, France
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Technology → Extended, Virtual & Augmented Reality
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Biosynex

    (Oct 12, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Doc2u

Doc2u offers a comprehensive portfolio of products and services, including Telemedicine Platform and Tensioflash.

Primary

Platform for remote medical consultations with integrated devices

Tool for remote blood pressure and vital sign monitoring

Funding Insights of Doc2u

Investors in Doc2u

Doc2u has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Biosynex.

All
Institutional
Investor Description Founded Year Domain Location
Professional rapid diagnostic tests for diseases are manufactured by Biosynex.
Founded Year Domain Location

Investments & Acquisitions by Doc2u

Investments

Financial Statements - Doc2u

Doc2u Comparisons

+
Add Comparison
Available on Premium

Competitors of Doc2u

Doc2u operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, Athelas and BioIntelliSense, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
domain founded_year HQ Location
Medical devices for structural heart disease are developed and provided.
domain founded_year HQ Location
Remote monitoring platform for tracking patient activity
domain founded_year HQ Location
Provider of smart solutions for monitoring heart rate, weight, and blood pressure
domain founded_year HQ Location
Vital signs are monitored via a single-use patch and platform.
domain founded_year HQ Location
Contactless patient monitoring is provided for mental health facilities.

Latest news on Doc2u

Frequently Asked Questions about Doc2u

Doc2u was founded in 2019.

Doc2u is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.

Doc2u was founded in 2019 and is based in Toulouse, France. Operations focus on the health technology sector, where digital devices are developed for remote patient monitoring. Services enable healthcare providers to track vital signs and health data securely from afar. The companys domain, doc2u.fr, supports these functions across European markets, emphasizing data integration for clinical use.

Doc2u's top competitors include Endotronix, Athelas and TestCard.

Doc2u offers Telemedicine Platform and Tensioflash.

Doc2u has 1 investor. Key investors include Biosynex.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available